Spirulina Supplementation and Infant Growth, Morbidity and Motor Development
Launched by PROGRAMME AGAINST MALNUTRITION · May 1, 2018
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
Micronutrient deficiency in the infancy is associated with growth faltering, morbidity, and delayed motor development, and is common in developing countries where the food available for infants has low micronutrient density.
A low-cost and sustainable way to address this problem is to utilize locally producible foods rich in multi-micronutrients as home supplements to complementary food. Arthrospira platensis, also known as spirulina, is a blue-green micro-algae indigenous to Africa.
It contains a high percentage of protein, and is rich in multiple micronutrients know to support infant gr...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All infants were eligible for the study if they are between 6 and 18 month of age
- Exclusion Criteria:
- • Non-singleton birth infants were excluded
About Programme Against Malnutrition
The Programme Against Malnutrition is a dedicated clinical trial sponsor focused on combating malnutrition through innovative research and evidence-based interventions. By facilitating the development and evaluation of novel therapeutic approaches, the programme aims to improve nutritional outcomes in vulnerable populations. Committed to collaboration with healthcare professionals, researchers, and community stakeholders, the initiative strives to advance knowledge, enhance treatment strategies, and ultimately reduce the global burden of malnutrition through rigorous clinical trials and data-driven insights.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mansa, Luapura, Zambia
Patients applied
Trial Officials
Kazuya Masuda, PhD
Principal Investigator
Hitotsubashi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials